By the end of 2019, the pre-filled syringes market will account for US$4.98 bn in revenue, say projections from Transparency Market Research. The business intelligence firm, in its latest report, titled ‘Prefilled Syringes Market - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2013 - 2019’, states that the market was worth US$2.09 bn in 2012. Based on these projections, the global prefilled syringes market is expected to exhibit a CAGR of 13.3% from 2013 to 2019.

Get Free Sample Research Report: 
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1131

In order to ensure sustained growth in the global prefilled syringes market, the report recommends companies to manufacture prefilled syringes using polymer technology, which results in lighter yet safer syringes. The North America prefilled syringes market is identified as being lucrative and a senior analyst from TMR says, “Within North America, the United States is an especially promising market for companies looking to boost their revenue. However, the regulatory landscape here calls for stricter compliance.” The key drivers identified by the market research report are: steady and consistent growth in the market for injectable drugs, rising adoption of point-of-care drug administration systems, and problems associated with the vial-and-syringe option that are prompting more healthcare practitioners to opt for prefilled syringes.

The report segments the global prefilled syringes market on the basis of key criteria for a detailed analysis of the market. By type of syringe, the report segments prefilled syringes into plastic and glass variants. While polymer syringes are gaining attention, it will be a few years before they become the syringe variant of choice among healthcare providers and consumers. Glass syringes continue to assert their dominance in the global prefilled syringes market, and will remain in this position over the forecast period of this report. The demand for glass syringes is expected to remain high in response to the growth of the biologics market.

Likewise, based on geography, the market is segmented into North America, Asia Pacific, Europe, and Rest of the World. Europe stood as the largest prefilled syringes market in 2012 in both volume and revenue terms. In the coming years, the North America prefilled syringes market is predicted to emerge as an attractive space for investors. The North America prefilled syringes market will have a compound annual growth rate (CAGR) of 15.0% between 2013 and 2019. More drug manufacturers are offering products in the injectable form, for which prefilled syringes have proven to be the most convenient product. The advent of prefilled syringes has also led to a decline in the sales of vials, indicating a change in consumer preference.

While developed countries in North America and Europe are expected to be pioneers in the prefilled syringes market, several national markets in Asia Pacific will remain late adopters. Although the prefillable syringes market in Asia Pacific currently occupies only a very small share in the global market, the rising spending power of consumers here will help change this situation. A rise in the number of patients diagnosed with chronic diseases and conditions will also propel the prefilled syringes market in Asia Pacific.Companies profiled in the prefilled syringes market report are: Becton, Dickinson & Company; Nipro Corporation; Gerresheimer AG; Schott AG; Stevanato Group.

Full Research Report on Global Prefilled Syringes Market: 
http://www.transparencymarketresearch.com/prefilled-syringes-market.html